Viewing Study NCT06462092


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2025-12-27 @ 5:18 AM
Study NCT ID: NCT06462092
Status: RECRUITING
Last Update Posted: 2025-09-29
First Post: 2024-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Sponsor: Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module